156 related articles for article (PubMed ID: 30334297)
1. Alteration in serum concentrations of FGF19, FGF21, and FGF23 in patients with urothelial carcinoma.
Li JR; Chiu KY; Ou YC; Wang SS; Chen CS; Yang CK; Ho HC; Cheng CL; Yang CR; Chen CC; Wang SC; Lin CY; Hung SC; Hsu CY; Chen CJ
Biofactors; 2019 Jan; 45(1):62-68. PubMed ID: 30334297
[TBL] [Abstract][Full Text] [Related]
2. N-glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas.
Kodama H; Yoneyama T; Tanaka T; Noro D; Tobisawa Y; Yamamoto H; Suto S; Hatakeyama S; Mori K; Yoneyama T; Hashimoto Y; Kakizaki I; Nakaji S; Ohyama C
Cancer Med; 2021 Feb; 10(4):1297-1313. PubMed ID: 33455069
[TBL] [Abstract][Full Text] [Related]
3. Use of the Nuclear Matrix Protein 22 BladderChek Test for the Detection of Primary and Recurrent Urothelial Carcinoma.
Xia CS; Fan CH; Su M; Wang QS; Bao HZ
Dis Markers; 2020; 2020():3424039. PubMed ID: 32454904
[TBL] [Abstract][Full Text] [Related]
4. Positive voided urine cytology predicts worse pathological findings of nephroureterectomy specimens in patients with upper tract urothelial carcinoma: does selective ureteral cytology have an additional efficacy?
Sakano S; Inamoto T; Inoue R; Matsumoto H; Nagao K; Yamamoto Y; Azuma H; Matsuyama H
Jpn J Clin Oncol; 2015 Oct; 45(10):968-72. PubMed ID: 26232447
[TBL] [Abstract][Full Text] [Related]
5. Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma.
Petros FG; Choi W; Qi Y; Moss T; Li R; Su X; Guo CC; Czerniak B; Dinney C; McConkey DJ; Matin SF
J Urol; 2021 Sep; 206(3):548-557. PubMed ID: 33881933
[TBL] [Abstract][Full Text] [Related]
6. Are urothelial carcinomas of the upper urinary tract a distinct entity from urothelial carcinomas of the urinary bladder? Behavior of urothelial carcinoma after radical surgery with respect to anatomical location: a case control study.
Kim M; Jeong CW; Kwak C; Kim HH; Ku JH
BMC Cancer; 2015 Mar; 15():149. PubMed ID: 25886012
[TBL] [Abstract][Full Text] [Related]
7. Serum periplakin as a potential biomarker for urothelial carcinoma of the urinary bladder.
Matsumoto K; Ikeda M; Matsumoto T; Nagashio R; Nishimori T; Tomonaga T; Nomura F; Sato Y; Kitasato H; Iwamura M
Asian Pac J Cancer Prev; 2014; 15(22):9927-31. PubMed ID: 25520130
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms on 8q24.1 and 4p16.3 are not linked with urothelial carcinoma of the bladder in contrast to their association with aggressive upper urinary tract tumours.
Yates DR; Rouprêt M; Drouin SJ; Audouin M; Cancel-Tassin G; Comperat E; Bitker MO; Cussenot O
World J Urol; 2013 Feb; 31(1):53-9. PubMed ID: 23053209
[TBL] [Abstract][Full Text] [Related]
9. Resection of the Intramural Portion of the Distal Ureter during Transurethral Resection of Bladder Tumors: Predictive Factors for Secondary Stenosis and Development of Upper Urinary Tract Recurrence.
Rodriguez Faba O; Gaya JM; Breda A; Juarez Del Dago P; Pisano F; Salas D; Palou J
J Urol; 2016 Jul; 196(1):52-6. PubMed ID: 26802584
[TBL] [Abstract][Full Text] [Related]
10. CKD as a risk factor for bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.
Chung SD; Huang KH; Lai MK; Huang CY; Chen CH; Pu YS; Yu HJ; Chueh SC
Am J Kidney Dis; 2007 Nov; 50(5):743-53. PubMed ID: 17954287
[TBL] [Abstract][Full Text] [Related]
11. Oncologic outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma.
Li WM; Shen JT; Li CC; Ke HL; Wei YC; Wu WJ; Chou YH; Huang CH
Eur Urol; 2010 Jun; 57(6):963-9. PubMed ID: 20079965
[TBL] [Abstract][Full Text] [Related]
12. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M;
BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
[TBL] [Abstract][Full Text] [Related]
13. Oncological impact of endoscopic bladder cuff management during nephroureterectomy varies according to upper urinary tract tumor location.
Luo HL; Kang CH; Chen YT; Chuang YC; Cheng YT; Lee WC; Chiang PH
Int J Urol; 2014 Apr; 21(4):366-9. PubMed ID: 24118071
[TBL] [Abstract][Full Text] [Related]
14. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
Aboumohamed AA; Krane LS; Hemal AK
J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
[TBL] [Abstract][Full Text] [Related]
15. Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas.
Tanaka T; Yoneyama T; Noro D; Imanishi K; Kojima Y; Hatakeyama S; Tobisawa Y; Mori K; Yamamoto H; Imai A; Yoneyama T; Hashimoto Y; Koie T; Tanaka M; Nishimura SI; Kurauchi S; Takahashi I; Ohyama C
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29210993
[TBL] [Abstract][Full Text] [Related]
16. FGF7 Over Expression is an Independent Prognosticator in Patients with Urothelial Carcinoma of the Upper Urinary Tract and Bladder.
Fan EW; Li CC; Wu WJ; Huang CN; Li WM; Ke HL; Yeh HC; Wu TF; Liang PI; Ma LJ; Li CF
J Urol; 2015 Jul; 194(1):223-9. PubMed ID: 25623741
[TBL] [Abstract][Full Text] [Related]
17. The effect of tumor location on prognosis in patients with primary ureteral urothelial carcinoma.
Li WM; Wu WJ; Li CC; Ke HL; Wei YC; Yeh HC; Chou YH; Huang CH; Huang CN
Urol Oncol; 2013 Nov; 31(8):1670-5. PubMed ID: 22687568
[TBL] [Abstract][Full Text] [Related]
18. Reduced levels of serum FGF19 and impaired expression of receptors for endocrine FGFs in adipose tissue from HIV-infected patients.
Gallego-Escuredo JM; Domingo P; Gutiérrez Mdel M; Mateo MG; Cabeza MC; Fontanet A; Vidal F; Domingo JC; Giralt M; Villarroya F
J Acquir Immune Defic Syndr; 2012 Dec; 61(5):527-34. PubMed ID: 23187887
[TBL] [Abstract][Full Text] [Related]
19. Micro RNA expression and prognosis in low-grade non-invasive urothelial carcinoma.
Dip N; Reis ST; Abe DK; Viana NI; Morais DR; Moura CM; Katz B; Silva IA; Srougi M; Leite KR
Int Braz J Urol; 2014; 40(5):644-9. PubMed ID: 25498275
[TBL] [Abstract][Full Text] [Related]
20. A proposed score for assessing progression in pT1 high-grade urothelial carcinoma of the bladder.
Raspollini MR; Minervini A; Lapini A; Lanzi F; Rotellini M; Baroni G; Carini M
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):218-27. PubMed ID: 22820663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
